Investors   |    About Cambrex   |    Contact Us   |    Careers   |    Login
Search Site
Advanced Search
Site Map
Cambrex Pharmaceutical Total Capabilities

You access a wide range of flexible manufacturing capacity when working with Cambrex Pharma. We are proud to offer extensive cGMP facilities in all scales, with full API manufacturing standards, plus a broad range of choice for production of pharmaceutical and other organic intermediates. 


Cambrex Pharma adheres to cGMP guidelines for Active Pharmaceutical Ingredients at all production scales: advanced R&D facilities at five sites and two state-of-the-art kilo labs; eight flexible pilot plants; and five full-scale operating sites with a total capacity of 875,000 liters.


Manufacturing Capabilities

 

  Cambrex Charles City  

Cambrex Karlskoga
Kilo Laboratory*

 Yes

 Yes

Pilot Capabilities
Total Pilot Plants

1

4

Total Reactor Capacity

 

 

   Liters  3.8m³ 22m³
   Gallons

 1000 gallon

5,218

Total Reactors (SS, GL, Hastelloy)

7

24

  Min-Max Liters

 110 - 1,130

150 - 3,000

  Min-Max Gallons  30 - 300  40 - 800

Centrifuges

1

7

 Driers

2

6

 Production trains

5

5

Full Scale Capabilities
Total Reactor Capacity

 

 

  Liters 357m³  311m³
  Gallons

 94,000

82,166

Total Reactors (SS, GL, Hastelloy)

48

71

  Min-Max Liters

 1,900-15,000

1,000 - 16,000

  Min-Max Gallons 500 - 4,000 260 - 4,220
Centrifuges

 10

20

Driers

 10

8

Production trains

 12

15

* Our North Brunswick facility has cGMP kil laboratories with Cat. 5 OEB capabilities.

Products/Services
Pharmaceutical
Proprietary Products
Generic Pharmaceutical
Manufacturing Services
Development Services
Technologies
About Us
Global Network
Capabilities
Regulatory
     
  ©Copyright 2008 Cambrex Corporation. Reproduction of any elements of this site for commercial use is prohibited. Please read our Privacy Policy and Disclaimers before proceeding though this site. Best viewed at a screen resolution of 1024 x 768 or higher.